Why is Genpharmasec Ltd ?
1
Poor Management Efficiency with a low ROE of 5.78%
- The company has been able to generate a Return on Equity (avg) of 5.78% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Operating profit has grown by an annual rate 18.74% of over the last 5 years
3
Stock is technically in a Bearish range
- The technical trend has deteriorated from Mildly Bearish on 28-Feb-25 and has generated -1.49% returns since then
- The stocks MACD and KST technical factors are also Bearish
4
With ROE of 4, it has a Expensive valuation with a 1.7 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -20.08%, its profits have risen by 132.2% ; the PEG ratio of the company is 0.4
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -20.08% returns in the last 1 year, the stock has also underperformed BSE 500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Trading)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Genpharmasec for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Genpharmasec
-20.08%
-0.39
51.69%
SENSEX
0.45%
0.04
14.48%
Quality key factors
Factor
Value
Sales Growth (5y)
22.37%
EBIT Growth (5y)
18.74%
EBIT to Interest (avg)
0.96
Debt to EBITDA (avg)
3.26
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.98
Tax Ratio
30.29%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.11%
ROE (avg)
5.78%
Valuation Key Factors 
Factor
Value
P/E Ratio
41
Industry P/E
22
Price to Book Value
1.66
EV to EBIT
72.89
EV to EBITDA
68.79
EV to Capital Employed
1.67
EV to Sales
3.72
PEG Ratio
0.43
Dividend Yield
NA
ROCE (Latest)
0.91%
ROE (Latest)
4.03%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
Technical Movement
13What is working for the Company
NET SALES(Q)
At Rs 8.48 cr has Grown at 22.0 %
PBDIT(Q)
Highest at Rs 0.73 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 8.61%
PBT LESS OI(Q)
Highest at Rs 0.48 cr.
PAT(Q)
Highest at Rs 0.78 cr.
EPS(Q)
Highest at Rs 0.01
-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Genpharmasec
Net Sales - Quarterly
At Rs 8.48 cr has Grown at 22.0 %
over average Net Sales of the previous four quarters of Rs 6.95 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 0.73 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 8.61%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 0.48 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 0.78 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 0.01
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)